Biological and Pharmaceutical Bulletin · 2008 · 31 citations · 21 references
MedicineNeurosciencePharmacologyBehavioral NeuroscienceNeuropharmacologyPain MedicineAnalgesiaAnalgesic PharmacologyCentral Nervous System Drug ActionsOpioid AnalgesicsOpioid PharmacologySerotonergic PharmacologyEndogenous OpioidsIntradermal AdministrationOpioid Modulation Of ItchOpioid Modulation Of PainOpioid Receptor ModulationScratching BehaviorSerotonergic ItchSerotonin Receptors
The present study was conducted to determine whether cutaneous itch involves mu-opioid receptors in either of the spinal cord or lower brainstem or in both regions in mice. An intraplantar injection of serotonin hydrochloride (100 nmol/site) induced biting, an itch-related behavior. The behavior was inhibited by subcutaneous (0.3-1 mg/kg) and intracisternal (1--10 nmol/site), but not intrathecal (1--10 nmol/site), injections of naloxone hydrochloride. An intradermal injection of serotonin (100 nmol/site) to the rostral back induced scratching, an itch-related behavior, which was inhibited by subcutaneous (1 mg/kg) and intracisternal (10 nmol/site) injections of naloxone. These results suggest that mu-opioid receptor in the lower brainstem, but not spinal cord, is a site of central pruritogenic action of opioids and is involved in the facilitatory regulation of itch signaling.
21
A potent and selective endogenous agonist for the µ-opiate receptor
James E. Zadina, Laszlo Hackler, Lin-Jun Ge et al. · Nature · 1997 · 1.3K citations
Randomised crossover trial of naltrexone in uraemic pruritus
Gary Peer, Shmuel Kivity, O. Agami et al. · The Lancet · 1996 · 298 citations
Nonrespiratory Side Effects of Epidural Morphine
Philip R. Bromage, Enrico M. Camporesi, Philippe A. C. Durant et al. · Anesthesia & Analgesia · 1982 · 238 citations